Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Estey

Showing results (71-80 of 204) with videos related to

Pageof 21
Sort By:
Seminars in Oncology|June 1, 1987
Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemiaE Estey, M J Keating, W Plunkett, et al.
Cancer Treatment Reports|September 1, 1986
Therapeutic response in phase I trials of antineoplastic agentsE Estey, D Hoth, R Simon, et al.
Leukemia & Lymphoma|November 9, 2001
Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acidE Estey, C Koller, J Cortes, et al.
Investigational New Drugs|January 1, 1985
Phase I evaluation of intravenous difluoromethylornithine--a polyamine inhibitorA M Maddox, M J Keating, K E McCredie, et al.
Blood|August 12, 2000
Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemiaM Albitar, M Beran, S O'Brien, et al.
Cancer|August 15, 1991
Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemiaS O'Brien, H Kantarjian, E Estey, et al.
Seminars in Oncology|June 1, 1985
Pharmacologically directed ara-C therapy for refractory leukemiaW Plunkett, S Iacoboni, E Estey, et al.
Biochemical and Biophysical Research Communications|January 29, 1986
The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA)M Bakic, M Beran, B S Andersson, et al.
Leukemia & Lymphoma|March 1, 1993
Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemiaE Estey, W Plunkett, V Gandhi, et al.
Leukemia|July 1, 1997
A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJ Cortes, H Kantarjian, S O'Brien, et al.
Pageof 21

Showing results (71-80 of 204) with videos related to

Sort By:
Pageof 21
Seminars in Oncology|June 1, 1987
Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemiaE Estey, M J Keating, W Plunkett, et al.
Cancer Treatment Reports|September 1, 1986
Therapeutic response in phase I trials of antineoplastic agentsE Estey, D Hoth, R Simon, et al.
Leukemia & Lymphoma|November 9, 2001
Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acidE Estey, C Koller, J Cortes, et al.
Investigational New Drugs|January 1, 1985
Phase I evaluation of intravenous difluoromethylornithine--a polyamine inhibitorA M Maddox, M J Keating, K E McCredie, et al.
Blood|August 12, 2000
Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemiaM Albitar, M Beran, S O'Brien, et al.
Cancer|August 15, 1991
Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemiaS O'Brien, H Kantarjian, E Estey, et al.
Seminars in Oncology|June 1, 1985
Pharmacologically directed ara-C therapy for refractory leukemiaW Plunkett, S Iacoboni, E Estey, et al.
Biochemical and Biophysical Research Communications|January 29, 1986
The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA)M Bakic, M Beran, B S Andersson, et al.
Leukemia & Lymphoma|March 1, 1993
Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemiaE Estey, W Plunkett, V Gandhi, et al.
Leukemia|July 1, 1997
A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJ Cortes, H Kantarjian, S O'Brien, et al.
Pageof 21